Icosavax, Inc.
ICVX · NASDAQ
9/30/2023 | 6/30/2023 | 3/31/2023 | 12/31/2022 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$22,041 | -$26,497 | -$24,561 | -$23,613 |
| Dep. & Amort. | $763 | $665 | $643 | $619 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $6,602 | $6,311 | $6,000 | $6,158 |
| Change in WC | -$2,829 | $1,414 | -$2,683 | $8,368 |
| Other Non-Cash | -$1,467 | -$1,115 | -$1,048 | -$536 |
| Operating Cash Flow | -$18,972 | -$19,222 | -$21,649 | -$9,004 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$32 | -$679 | -$1,573 | -$2,550 |
| Net Acquisitions | $0 | $0 | -$13,600 | $0 |
| Inv. Purchases | -$112,372 | $0 | -$50,000 | -$50,063 |
| Inv. Sales/Matur. | $39,750 | $56,501 | $63,600 | $48,500 |
| Other Inv. Act. | $0 | $0 | $13,600 | -$2,629 |
| Investing Cash Flow | -$72,654 | $55,822 | $12,027 | -$6,742 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | -$269 | $68,071 | $117 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$208 | $68,071 | $117 | $10,087 |
| Financing Cash Flow | -$208 | $68,071 | $117 | $10,087 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$91,834 | $104,671 | -$9,505 | -$5,659 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $155,073 | $50,402 | $59,907 | $65,566 |
| End Cash | $63,239 | $155,073 | $50,402 | $59,907 |
| Free Cash Flow | -$19,004 | -$19,901 | -$23,222 | -$11,554 |